Eur J Clin Investig 27:533536 von Websky K, Reichetzeder C, Hocher B (2014) Physiology and pathophysiology of incretins in the kidney
Data availability The data generated were submitted to the EMBL-EBI MetaboLights database with the identifier MTBLS1294 ( References Tandogdu, Z
For people who stopped taking GLP-1 weight-loss medications, patients regained about 60% of the weight they lost within a year, according to the review's analysis
CJC-1295 incorporates four amino acid substitutions that protect it from DPP-IV cleavage, extending the unmodified peptide's half-life to approximately 30 minutes
Who is it for: Medication eligibility and prescriptions are determined solely by licensed medical providers based on clinical appropriateness
Penin, F., Dubuisson, J., Rey, F